Founded: 1997 Headquarters: Plymouth
Chief executive: Dan Sullivan
Employees: 100
2007 revenue: $1.5 million
Investors: OrbiMed Advisors, Oxford Bioscience Partners, CIBC World Markets, Pfizer Strategic Investments Group
Business: Developed GPS-like technology that allows doctors to take tissue samples from suspected cancerous lesions deep in the lungs.
